Now showing items 1-2 of 2
The importance of age effects on performance in the assessment of clinical trials
(Elsevier, 1973-11)
Forty young adult normal subjects, 10 Parkinson's disease patients and their 10 matched normal subjects, and 10 multiple sclerosis patients and their 10 matched normal subjects were evaluated in the Quantitative Examination ...
A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's disease
(Elsevier, 1972-03)
A double-blind crossover trial of amantadine vs. placebo was carried out involving 42 patients with Parkinson's disease: 64 per cent of the patients on amantadine experienced subjective improvement compared to 21 per cent ...